A doctor at the Corporal Michael J. Crescenz Department of Veterans Affairs Medical Center, in Philadelphia, found that a patient at the center had experienced a false positive urine test after taking empagliflozin, an SGLT2 ...
For patients with primary biliary cholangitis, more receiving the peroxisome proliferator-activated receptor delta (PPARδ) agonist seladelpar have a biochemical response and alkaline phosphatase normalization, according ...
Feb 27, 2024
0
0
A drug can make life safer for children with food allergies by preventing dangerous allergic responses to small quantities of allergy-triggering foods, according to a new study led by scientists at the Stanford School of ...
Feb 25, 2024
0
50
An international team has identified a new therapeutic for patients with a rare autoimmune disease called eosinophilic granulomatosis with polyangiitis (EGPA). A biologic drug called benralizumab has been shown to be non-inferior ...
Feb 23, 2024
0
1
CD19 chimeric antigen receptor (CAR) T-cell therapy seems feasible, safe, and efficacious for patients with different autoimmune diseases, according to a study published in the Feb. 22 issue of the New England Journal of ...
Feb 22, 2024
0
40
Alzheimer's quietly ravages the brain long before symptoms appear and now scientists have new clues about the dominolike sequence of those changes—a potential window to one day intervene.
Feb 22, 2024
0
2
A novel treatment for polycythemia vera, a potentially fatal blood cancer, demonstrated the ability to control overproduction of red blood cells, the hallmark of this malignancy and many of its debilitating symptoms in a ...
Feb 21, 2024
0
53
The addition of electronic cigarettes to standard smoking-cessation counseling results in greater abstinence from tobacco use among smokers than smoking-cessation counseling alone, according to a study published in the Feb. ...
Feb 19, 2024
0
0
A review paper, published in the New England Journal of Medicine, focuses on how fungal diseases present in people with healthy immune systems and examines current diagnostics and treatments.
Feb 16, 2024
0
23
For patients with relapsing multiple sclerosis, the anti-CD40L monoclonal antibody frexalimab has a favorable effect on the number of new gadolinium-enhancing T1-weighted lesions, according to a study published in the Feb. ...
Feb 15, 2024
0
0
